
Phio Pharmaceuticals Corp.
PHIONasdaqCIK 1533040HealthcareFiscal year ends Dec 31
Reports and events: 316 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-11-3016:45 ET | DEF 14A | Proxy statementPeriod 2023-01-04 | 0001683168-22-008106 |
| 2022-11-1617:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001683168-22-007821 |
| 2022-11-1017:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-22-007530 |
| 2022-11-1017:01 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001683168-22-007528 |
| 2022-09-2908:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-22-006665 |
| 2022-08-2616:05 ET | 8-K | 3.01 Delisting notice | 0001683168-22-006086 |
| 2022-08-1216:15 ET | 8-K | 5.07 Shareholder vote results | 0001683168-22-005634 |
| 2022-08-1117:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-22-005566 |
| 2022-08-1116:51 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001683168-22-005565 |
| 2022-06-3016:30 ET | DEF 14A | Proxy statementPeriod 2022-08-09 | 0001683168-22-004728 |
| 2022-05-1217:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-22-003517 |
| 2022-05-1216:51 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001683168-22-003516 |
| 2022-05-1017:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001683168-22-003391 |
| 2022-05-0207:30 ET | 8-K | 5.01 Change in control; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001683168-22-003069 |
| 2022-04-2916:45 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0001683168-22-003052 |
| 2022-03-2217:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-22-001835 |
| 2022-03-2217:00 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001683168-22-001833 |
| 2022-03-0317:15 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001683168-22-001424 |
| 2021-11-1016:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-21-005423 |
| 2021-11-1016:31 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001683168-21-005420 |
| 2021-08-1217:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-21-003479 |
| 2021-08-1217:01 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001683168-21-003476 |
| 2021-06-2116:45 ET | 8-K | 5.07 Shareholder vote results | 0001683168-21-002649 |
| 2021-05-1317:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-21-001972 |
| 2021-05-1317:08 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001683168-21-001971 |
| 2021-04-3017:00 ET | DEF 14A | Proxy statementPeriod 2021-06-15 | 0001683168-21-001666 |
| 2021-03-2517:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-21-001063 |
| 2021-03-2517:15 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001683168-21-001062 |
| 2021-02-1716:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-21-000600 |
| 2021-01-2517:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-21-000249 |
| 2020-11-1017:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-20-003810 |
| 2020-11-1017:00 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001683168-20-003809 |
| 2020-10-1316:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001683168-20-003428 |
| 2020-08-2817:00 ET | DEF 14A | Proxy statementPeriod 2020-10-08 | 0001683168-20-002903 |
| 2020-08-1217:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-20-002650 |
| 2020-08-1217:00 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001683168-20-002649 |
| 2020-07-0917:20 ET | S-1 | Registration statement | 0001683168-20-002231 |
| 2020-05-2817:15 ET | S-1/A | Registration statement, amended | 0001683168-20-001772 |
| 2020-05-1217:11 ET | S-1 | Registration statement | 0001683168-20-001524 |
| 2020-05-1216:36 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001683168-20-001520 |
| 2020-05-1216:36 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001683168-20-001519 |
| 2020-04-0217:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-20-001071 |
| 2020-03-2617:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-20-000971 |
| 2020-03-2617:25 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001683168-20-000969 |
| 2020-03-1216:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-20-000783 |
| 2020-02-1317:25 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-20-000483 |
| 2020-02-1008:00 ET | 8-K | 8.01 Other events | 0001683168-20-000420 |
| 2020-02-0714:30 ET | S-1/A | Registration statement, amended | 0001683168-20-000390 |
| 2020-02-0617:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-20-000378 |
| 2020-01-3117:28 ET | S-1/A | Registration statement, amended | 0001683168-20-000317 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 20:44 ET. Listed shows no prices and gives no investment advice.